Geneos Wealth Management’s Greenwich LifeSciences GLSI Stock Holding History

Geneos Wealth Management’s Portfolio GLSI Stock Details GLSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.11K	Hold	88	–	–	﹤0.01%	2311
2025 Q4	$1.85K	Hold	88	–	–	﹤0.01%	2327
2025 Q3	$876	Hold	88	–	–	﹤0.01%	2417
2025 Q2	$798	Sell	88 -88	-50%	-$837	﹤0.01%	3042
2025 Q1	$1.68K	Buy	176 +88	+100%	+$1.07K	﹤0.01%	2996
2024 Q4	$988	Hold	88	–	–	﹤0.01%	2771
2024 Q3	$1.26K	Hold	88	–	–	﹤0.01%	2393
2024 Q2	$1.52K	Hold	88	–	–	﹤0.01%	1929
2024 Q1	$1.75K	Hold	88	–	–	﹤0.01%	1921
2023 Q4	$926	Hold	88	–	–	﹤0.01%	2023
2023 Q3	$778	Hold	88	–	–	﹤0.01%	2057
2023 Q2	$849	Buy	+88	New	+$984	﹤0.01%	2034

Other funds holding GLSI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Geneos Wealth Management's GLSI Position: Q1 2026 in Review

Geneos Wealth Management held its Greenwich LifeSciences (GLSI) position steady in Q1 2026 at 88 shares worth $2.11K. The position accounts for ﹤0.01% of the portfolio, ranked #2311.

Geneos Wealth Management first reported a position in GLSI in Q2 2023 and has held it in 12 quarters since. 64 funds tracked by Wall St. Rank hold GLSI as of Q1 2026.

Geneos Wealth Management held 88 shares of Greenwich LifeSciences worth $2.11K as of Q1 2026.
Geneos Wealth Management left its Greenwich LifeSciences share count unchanged in Q1 2026.
Greenwich LifeSciences made up ﹤0.01% of Geneos Wealth Management's portfolio in Q1 2026, its #2311 holding.
Geneos Wealth Management first reported a position in Greenwich LifeSciences in Q2 2023 and has held it in 12 quarters since.
64 funds tracked by Wall St. Rank held Greenwich LifeSciences as of Q1 2026.

Based on Geneos Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.